Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Change in Acquisitions & Divestments (2016 - 2022)

Usana Health Sciences (USNA) has disclosed Change in Acquisitions & Divestments for 8 consecutive years, with $4.5 million as the latest value for Q3 2022.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A to $4.5 million in Q3 2022 year-over-year; TTM through Sep 2023 was $4.5 million, a 67.75% increase, with the full-year FY2024 number at $1.1 million, down 70.2% from a year prior.
  • Change in Acquisitions & Divestments was $4.5 million for Q3 2022 at Usana Health Sciences, up from -$1.8 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $36.7 million in Q1 2019 to a low of -$36.6 million in Q2 2019.
  • A 5-year average of $2.1 million and a median of $301000.0 in 2018 define the central range for Change in Acquisitions & Divestments.
  • Peak YoY movement for Change in Acquisitions & Divestments: skyrocketed 48700.0% in 2018, then crashed 920.65% in 2019.
  • Usana Health Sciences' Change in Acquisitions & Divestments stood at $18.1 million in 2018, then tumbled by 109.44% to -$1.7 million in 2019, then surged by 208.5% to $1.8 million in 2020, then crashed by 97.24% to $51000.0 in 2021, then soared by 8731.37% to $4.5 million in 2022.
  • Per Business Quant, the three most recent readings for USNA's Change in Acquisitions & Divestments are $4.5 million (Q3 2022), -$1.8 million (Q1 2022), and $51000.0 (Q2 2021).